enabled, A dosage-sensitive suppressor of mutations in the Drosophila Abl tyrosine kinase, encodes an Abl substrate with SH3 domain-binding properties

Genes and Development

Volumn 9, Issue 5, 1995, Pages 521-533

  Gertler, Frank B ^a,b   Comer, Allen R ^a   Juang, Jyh Lyh ^a   Ahern, Shawn M ^a   Clark, Michael J ^a   Liebl, Eric C ^a,c   Hoffmann, F Michael ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

^c DENISON UNIVERSITY   (United States)

Author keywords

Abl tyrosine kinase; Drosophila; enabled; SH3 domain; tyrosine phosphorylation

Indexed keywords

DNA BINDING PROTEIN; PROTEIN TYROSINE KINASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DROSOPHILA; EMBRYO; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; MALE; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION;

ANIMALIA; ENA;

EID: 0028969388     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.9.5.521     Document Type: Article

References (54)

1. Andoniou, C.E., C.B.F. Thien, and W.Y. Langdon. 1994. Tumour induction by activated ab1 involves tyrosine phosphorylation of the product of the cb1 oncogene. EMBO J. 13: 4515-4523.
2. Ashburner, M. 1989. Drosophila: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
3. Bar-Sagi, D., D. Rotin, A. Batzer, V. Mandiyan, and J. Schlessinger. 1993. SH3 domains direct cellular localization of signaling molecules. Cell 74: 83-91.
4. Baskaran, R., M.E. Dahmus, and J.Y.J. Wang. 1993. Tyrosine phosphorylation of mammalian RNA polymerase II carboxy-terminal domain. Proc. Natl. Acad. Sci. 90: 11167-11171.
5. Ben-Neriah, Y. and D. Baltimore. 1986. Structural modification of c-Abl in lymphoma and leukemia. Curr. Topics Microbiol. Immunol. 132: 82-89.
6. Bennett, R.L. and F.M. Hoffmann. 1992. Increased levels of the Drosophila Abelson tyrosine kinase in nerves and muscles: Subcellular localization and mutant phenotypes imply a role in cell-cell interactions. Development 116: 953-966.
7. Brand, A.H. and N. Perrimon. 1993. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118: 401-415.
8. Brown, N. and F. Kafatos. 1988. Functional Drosophila cDNA libraries from Drosophila embryos. J. Mol. Biol. 203: 425-437.
9. Cheng, G., Z.-S. Ye, and D. Baltimore. 1994. Binding of Bruton's tyrosine kinase to fyn, lyn or hck through a Src homology 3 domain-mediated interaction. Proc. Natl. Acad. Sci. 91: 8152-8155.
10. Cooper, J.A., B.M. Sefton, and T. Hunter. 1983. Detection and quantification of phosphotyrosine in proteins. In Methods Enzymol. 99: 387-402.
11. Elkins, T., K. Zinn, L. McAllister, P.M. Hoffmann, and C.S. Goodman. 1990. Genetic analysis of a Drosophila neural cell adhesion molecule: Interaction of fasciclin I and Abelson tyrosine kinase mutations. Cell 60: 565-575.
12. Feller, S.M., B. Knudsen, and H. Hanafusa. 1994. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 13: 2341-2351.
13. Gertler, F.B., R.L. Bennett, M.J. Clark, and F.M. Hoffmann. 1989. Drosophila ab1 tyrosine kinase in embryonic CNS axons: A role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell 58: 103-113.
14. Gertler, F.B., K.K. Hill, M.J. Clark, and F.M. Hoffmann. 1993. Dosage-sensitive modifiers of Drosophila ab1 tyrosine kinase function: Prospero, a regulator of axonal outgrowth, and disabled, a novel tyosine kinase substrate. Genes & Dev. 7: 441-453.
15. Gertler, F.B., J.S. Doctor, and F.M. Hoffmann. 1990. Genetic suppression of mutations in the Drosophila ab1 proto-oncogene homolog. Science 248: 857-860.
16. Gout, I., R. Dhand, I.D. Hiles, M.J. Fry, G. Panayotou, P. Das, O. Truong, N.F. Totty, J. Hsuan, G.W. Booker, I.D. Campbell, and M.D. Waterfield. 1993. The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell 75: 25-36.
17. Harlow, E. and D. Lane. 1988. Antibodies: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
18. Henkemeyer, M.J., F.B. Gertler, W. Goodman and F.M. Hoffmann. 1987. The Drosophila Abelson proto-oncogene homolog: Identification of mutant alleles that have pleiotropic effects late in development. Cell 51: 821-828.
19. Henkemeyer, M.J., R.L. Bennett, F.B. Gertler and F.M. Hoffmann. 1988. DNA sequence, structure, and tyrosine kinase activity of the Drosophila melanogaster Abelson proto-oncogene homolog. Mol. Cell. Biol. 8: 843-853.
20. Henkemeyer, M., S.R. West, F.B. Gertler, and F.M. Hoffmann. 1990. A novel tyrosine kinase-independent function of Drosophila ab1 correlates with proper subcellular localization. Cell 63: 949-960.
21. Hoffmann, F.M. 1991. Drosophila abl and genetic redundancy in signal transduction. Trends Genet. 7: 351-355.
22. Kipreos, E.T. and J.Y. Wang. 1992. Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science 256: 382-385.
23. Kloetzer, W., R. Kurzrock, L. Smith, M. Talpaz, M. Spiller, J. Gutterman, and R.B. Arlinghaus. 1985. The human cellular ab1 gene product in the chronic myelogenous leukemia cell line has an associated tyrosine protein kinase activity. Virology 140: 230-238.
24. Konopka, J.B., S.M. Watanabe, and O.N. Witte. 1985. An alteration of the human c-ab1 protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37: 1035-1042.
25. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
26. Liu, J., M. Campbell, J.Q. Guo, D. Lu, Y.M. Xian, B.S. Andersson, and R.B. Arlinghaus. 1993. BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates p160 BCR on tyrosine predominantly within the first BCR exon. Oncogene 8: 101-109.
27. Matsuguchi, T., R. Salgia, M. Hallek, M. Eder, B. Druker, T.J. Ernst, and J.D. Griffin. 1994. Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210BCR/ABL. J. Biol. Chem. 269: 5016-5021.
28. McWhirter, J.R. and J.Y.J. Wang. 1991. Activation of tyrosine kinase and microfilament-binding functions of c-ab1 by bcr sequences in bcr/ab1 fusion proteins. Mol. Cell. Biol. 11: 1553-1565.
29. _. 1993. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12: 1533-1546.
30. Olivier, J.P., T. Raabe, M. Henkemeyer, B. Dickson, G. Mbamalu, B. Margolis, J. Schlessinger, E. Hafen, and T. Pawson. 1993. A Drosophila SH2-SH3 adaptor protein implicated in coupling the sevenless tyrosine kinase to an activator of ras guanine nucleotide exchange, Sos. Cell 73: 171-179.
31. Panchamoorthy, G., T. Fukazawa, L. Stolz, G. Payne, K. Reedquist, S. Shoelson, Z. Songyang, L. Cantley, C. Walsh, and H. Band. 1994. Physical and functional interactions between SH2 and SH3 domains of the src family protein tyrosine kinase p59fyn. Mol. Cell. Biol. 14: 6372-6385.
32. Patel, N.H., P.M. Snow, and C.S. Goodman. 1987. Characterization and cloning of fasciclin III: A glycoprotein expressed on a subset of neurons and axon pathways in Drosophila. Cell 48: 975-988.
33. Pendergast, A.M., A.J. Muller, M.H. Havlik, R. Clark, F. McCormick, and O.N. Witte. 1991. Evidence for regulation of the human Abl tyrosine kinase by a cellular inhibitor. Proc. Natl. Acad. Sci. 88: 5927-5931.
34. Pendergast, A.M., L.A. Quilliam, L.D. Cripe, C.H. Bassing, Z. Dai, N. Li, A. Batzer, K.M. Rabun, C.J. Der, J. Schlessinger, and M.L. Gishizky. 1993. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB2 adaptor protein. Cell 75: 175-185.
35. Pleiman, C.M., W.M. Hertz and J.C. Cambier. 1994. Activation of phosphatidylinositol-3′ kinase by Src-family kinase SH3 binding to the p85 subunit. Science 263: 1609-1612.
36. Puil, L., J. Liu, G. Gish, G. Mbamalu, D. Bowtell, P.G. Pelicci, R. Arlinghaus, and T. Pawson. 1994. Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J. 13: 764-773.
37. Ren, R., B.J. Mayer, P. Cicchetti and D. Baltimore. 1993. Identification of a ten-amino acid proline-rich SH3 binding site. Science 259: 1157-1161.
38. Ren, R., Z.-S. Ye, and D. Baltimore. 1994. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes & Dev. 8: 783-795.
39. Reuther, G.W., H. Fu, L.D. Cripe, R.J. Collier, and A.M. Pendergast. 1994. Association of the protein kinases c-bcr and bcr-abl with proteins of the 14-3-3 family. Science 266: 129-133.
40. Robbins, A., W.S. Dynan, A. Greenleaf, and R. Tjian. 1984. Affinity-purified antibody as a probe of RNA polymerase II subunit structure. J. Mol. Appl. Genet. 2: 343-353.
41. Sawyers, C.L., J. McLaughlin, A. Goga, M. Havlik, and O. Witte. 1994. The nuclear tyrosine kinase c-abl negatively regulates cell growth. Cell 77: 121-131.
42. ml mutation show poor viability and depletion of selected B and T cell populations. Cell 65: 1165-1175.
43. Shtivelman, E., B. Lifshitz, R.P. Gale, and E. Canaani. 1985. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature 315: 550-554.
44. Simon, M.A., G.S. Dodson, and G.M. Rubin. 1993. An SH3-SH2-SH3 protein is required for p21Ras1 activation and binds to Sevenless and Sos proteins in vitro. Cell 73: 169-177.
45. Smith, D.B. and K.S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione-S transferase. Gene 67: 31-40.
46. Songyang, Z., S.E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W.G. Haser, F. King, T. Roberts, S. Ratnofsky, R.J. Lechleider, B.G. Neel, R.B. Birge, J.E. Fajardo, M. Chou, H. Hanafusa, B. Schaffhausen, and L.C. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72: 767-778.
47. Tauchi, T., G.-S. Feng, R. Shen, H.Y. Song, D. Donner, T. Pawson, and H.E. Broxmeyer. 1994. SH2-containing phosphotyrosine phosphatase Syp is a target of p210bcr-abl tyrosine kinase. J. Biol. Chem 269: 15381-15387.
48. Tybulewicz, V.L.J., C.E. Crawford, P.K. Jackson, R.T. Bronson, and R.C. Mulligan. 1991. Neonatal lethality and lymphonemia in mice with a disruption of the c-abl proto-oncogene. Cell 65: 1153-1163.
49. Van Etten, R.A., P. Jackson, and D. Baltimore. 1989. The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58: 669-678.
50. Van Etten, R.A., P.K. Jackson, D. Baltimore, M.C. Sanders, P.T. Matsudaira, and P.A. Janmey. 1994. The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J. Cell Biol. 124: 325-340.
51. Wang, J.Y.J. 1993. Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr. Opin. Genet. Dev. 3: 35-43.
52. Welch, P.J. and J.Y.J. Wang. 1993. A C-terminal protein binding domain in the retinoblastoma protein regulates nuclear c-abl tyrosine kinase in the cell cycle. Cell 75: 779-790.
53. Weng, Z., S.M. Thomas, R.J. Rickles, J.A. Taylor, A.W. Brauer, C. Seidel-Dugan, W.M. Michael, G. Dreyfuss, and J.S. Brugge. 1994. Identification of Src, Fyn, and Lyn SH3 binding proteins: Implications for a function of SH3 domains. Mol. Cell. Biol. 14: 4509-4521.
54. Wetzler, M., M. Talpaz, R.A. Van Etten, C. Hirsch-Ginsberg, M. Beran, and R. Kurzrock. 1994. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J. Clin. Invest. 92: 1925-1939.